To further verify the high TNIP1 levels in glioma tissue, we collected 20 glioblastoma samples and examined the expression of TNIP1 by immunohistochemical, immunoblot and quantitative polymerase chain reaction (qPCR) analyses (Figure 1E,F,G). This evidence concerns the gene TNIP1 and central nervous system cancer.